Psychedelic Depression Study - Treatment-Resistant Depression
Are you or a loved one living with Depression and currently taking antidepressant medication that doesn’t seem to help?
Segal Trials is conducting an outpatient clinical research study investigating a phase III, multi center, randomized, double-blind, controlled study to investigate the efficacy, safety, and tolerability of two administrations of COMP360 in participants with treatment-resistant depression.